Wikipedia -WSS

Wikipedia

author：comprehensive 2025-10-08 20:44:17 - browse：6

A handout illustration representing Google’s DeepMind subsidiary and Isomorphic Labs developed an AI model that can accurately predict how a vast universe of biomolecules interact on an atomic level. — DeepMind

Google on Wednesday unveiled an artificial intelligence tool capable of predicting the structure and interaction of a vast universe of biomolecules, a fundamental advance that may help scientists unravel poorly understood aspects of biology and disease.

The new AI, dubbed AlphaFold 3, improves upon earlier versions of the model by predicting not just the structure of proteins, but all the molecules that interact with them in cells, including RNA, DNA, ions, and other small molecules.

Most new drugs consist of small molecules designed to bind to a protein involved in disease. AlphaFold 3 opens broader avenues of exploration, allowing scientists to rapidly examine complex interactions with other molecules that may highlight new disease targets — and different ways of attacking them.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

hotspot

WSS

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Sen. Paul opposes bill to ban Chinese biotechs

A deep dive into Applied Therapeutics’ data, and questions on Cassava

Amylyx ALS drug failure raises questions and concerns

Erich Jarvis studies song birds to learn about human stuttering

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

hotspot

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

knowledge

Supreme Court strikes down use of affirmative action

Mirador, a new biotech startup, launches with $400 million

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Chinese researcher claims birth of first gene

How one medical school became remarkably diverse

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Heart attack and stroke risk calculators need revising

CDC marks new Covid

George Santos makes 1st court appearance after pleading not guilty to 13 counts

The problem with charging patients to message their doctors

focus

Sen. Paul opposes bill to ban Chinese biotechs

This gene therapy has record $4.25 million price. It's saved children.

What it’s like to watch children die of measles

Diabetes management: Digital health tools fall short, study says

CRISPR technology availability, affordability needs to be expanded

RSV shot was 90% effective at preventing hospitalizations in kids

explore

hotspot

focus

explore